-
1
-
-
0031721511
-
Calasenilin, a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment
-
Buxbaum, J.D., Choi, E.K., Luo, Y., Lilliehook, C., Crowley, A.C., Merriam, D.E. and Wasco, W. (1998) Calasenilin, a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat. Med., 4, 1177-1181.
-
(1998)
Nat. Med.
, vol.4
, pp. 1177-1181
-
-
Buxbaum, J.D.1
Choi, E.K.2
Luo, Y.3
Lilliehook, C.4
Crowley, A.C.5
Merriam, D.E.6
Wasco, W.7
-
3
-
-
0034598810
-
Modulation of A-type potassium channels by a family of calcium sensors
-
An, W.F., Bowlby, M.R., Betty, M., Cao, J., Ling, H.P., Mendoza, G., Hinson, J.W., Mattsson, K.I., Strassle, B.W., Trimmer, J.S. et al. (2000) Modulation of A-type potassium channels by a family of calcium sensors. Nature, 403, 553-556.
-
(2000)
Nature
, vol.403
, pp. 553-556
-
-
An, W.F.1
Bowlby, M.R.2
Betty, M.3
Cao, J.4
Ling, H.P.5
Mendoza, G.6
Hinson, J.W.7
Mattsson, K.I.8
Strassle, B.W.9
Trimmer, J.S.10
-
4
-
-
0035291187
-
Pro-apoptotic function of calsenilin/DREAM/KChIP3
-
Jo, D.G., Kim, M.J., Choi, Y.H., Kim, I.K., Song, Y.H., Woo, H.N., Chung, C.W. and Jung, Y.K. (2001) Pro-apoptotic function of calsenilin/ DREAM/KChIP3. FASEB J., 15, 589-591.
-
(2001)
FASEB J.
, vol.15
, pp. 589-591
-
-
Jo, D.G.1
Kim, M.J.2
Choi, Y.H.3
Kim, I.K.4
Song, Y.H.5
Woo, H.N.6
Chung, C.W.7
Jung, Y.K.8
-
5
-
-
0942276796
-
Induction of pro-apoptotic calsenilin/DREAM/KChIP3 in Alzheimer's disease and cultured neurons after amyloid-β exposure
-
Jo, D.G., Lee, J.Y., Hong, Y.M., Song, S., Mook-Jung, I., Koh, J.Y. and Jung, Y.K. (2004) Induction of pro-apoptotic calsenilin/DREAM/KChIP3 in Alzheimer's disease and cultured neurons after amyloid-β exposure. J. Neurochem., 88, 604-611.
-
(2004)
J. Neurochem.
, vol.88
, pp. 604-611
-
-
Jo, D.G.1
Lee, J.Y.2
Hong, Y.M.3
Song, S.4
Mook-Jung, I.5
Koh, J.Y.6
Jung, Y.K.7
-
6
-
-
0036251786
-
Calsenilin enhances apoptosis by altering endoplasmic reticulum calcium signaling
-
Lilliehook, C., Chan, S., Choi, E.K., Zaidi, N.F., Wasco, W., Mattson, M.P. and Buxbaum, J.D. (2002) Calsenilin enhances apoptosis by altering endoplasmic reticulum calcium signaling. Mol. Cell. Neurosci., 19, 552-559.
-
(2002)
Mol. Cell. Neurosci.
, vol.19
, pp. 552-559
-
-
Lilliehook, C.1
Chan, S.2
Choi, E.K.3
Zaidi, N.F.4
Wasco, W.5
Mattson, M.P.6
Buxbaum, J.D.7
-
7
-
-
0038069158
-
Contribution of presenilin/g-secretase to calsenilin-mediated apoptosis
-
Jo, D.G., Chang, J.W., Hong, H.S., Mook-Jung, I. and Jung, Y.K. (2003) Contribution of presenilin/g-secretase to calsenilin-mediated apoptosis. Biochem. Biophys. Res. Commun., 305, 62-66.
-
(2003)
Biochem. Biophys. Res. Commun.
, vol.305
, pp. 62-66
-
-
Jo, D.G.1
Chang, J.W.2
Hong, H.S.3
Mook-Jung, I.4
Jung, Y.K.5
-
8
-
-
0038692869
-
Phosphorylation of calsenilin at Ser63 regulates its cleavage by caspase-3
-
Choi, E.K., Miller, J.S., Zaidi, N.F., Salih, E., Buxbaum, J.D. and Wasco, W. (2003) Phosphorylation of calsenilin at Ser63 regulates its cleavage by caspase-3. Mol. Cell. Neurosci., 23, 495-506.
-
(2003)
Mol. Cell. Neurosci.
, vol.23
, pp. 495-506
-
-
Choi, E.K.1
Miller, J.S.2
Zaidi, N.F.3
Salih, E.4
Buxbaum, J.D.5
Wasco, W.6
-
9
-
-
0035374675
-
Calsenilin is a substrate for caspase-3 that preferentially interacts with the familial Alzheimer's disease-associated C-terminal fragment of presenilin 2
-
Choi, E.K., Zaidi, N.F., Miller, J.S., Crowley, A.C., Merriam, D.E., Lilliehook, C., Buxbaum, J.D. and Wasco, W. (2001) Calsenilin is a substrate for caspase-3 that preferentially interacts with the familial Alzheimer's disease-associated C-terminal fragment of presenilin 2. J. Biol. Chem., 276, 19197-19204.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 19197-19204
-
-
Choi, E.K.1
Zaidi, N.F.2
Miller, J.S.3
Crowley, A.C.4
Merriam, D.E.5
Lilliehook, C.6
Buxbaum, J.D.7
Wasco, W.8
-
10
-
-
16444380011
-
Expression of calsenilin in neurons and astrocytes in the Alzheimer's disease brain
-
Jin, J.K., Choi, J.K., Wasco, W., Buxbaum, J.D., Kozlowski, P.B., Carp, R.I., Kim, Y.S. and Choi, E.K. (2005) Expression of calsenilin in neurons and astrocytes in the Alzheimer's disease brain. Neuroreport, 16, 451-455.
-
(2005)
Neuroreport
, vol.16
, pp. 451-455
-
-
Jin, J.K.1
Choi, J.K.2
Wasco, W.3
Buxbaum, J.D.4
Kozlowski, P.B.5
Carp, R.I.6
Kim, Y.S.7
Choi, E.K.8
-
11
-
-
0037417183
-
Reduced expression of calsenilin/DREAM/KChIP3 in the brains of kainic acid-induced seizure and epilepsy patients
-
Hong, Y.M., Jo, D.G., Lee, M.C., Kim, S.Y. and Jung, Y.K. (2003) Reduced expression of calsenilin/DREAM/KChIP3 in the brains of kainic acid-induced seizure and epilepsy patients. Neurosci. Lett., 340, 33-36.
-
(2003)
Neurosci. Lett.
, vol.340
, pp. 33-36
-
-
Hong, Y.M.1
Jo, D.G.2
Lee, M.C.3
Kim, S.Y.4
Jung, Y.K.5
-
12
-
-
0029147298
-
Isolation of a novel gene underlying Batten disease, CLN3
-
Batten Disease Consortium, International
-
Batten Disease Consortium, International (1995) Isolation of a novel gene underlying Batten disease, CLN3. Cell, 82, 949-957.
-
(1995)
Cell
, vol.82
, pp. 949-957
-
-
-
13
-
-
0031985964
-
Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease
-
Järvelä, I., Sainio, M., Rantamäki, T., Olkkonen, V.M., Carpen, O., Peltonen, L. and Jalanko, A. (1998) Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. Hum. Mol. Genet., 7, 85-90.
-
(1998)
Hum. Mol. Genet.
, vol.7
, pp. 85-90
-
-
Järvelä, I.1
Sainio, M.2
Rantamäki, T.3
Olkkonen, V.M.4
Carpen, O.5
Peltonen, L.6
Jalanko, A.7
-
14
-
-
0034701293
-
Batten disease: Evaluation of CLN3 mutations on protein localization and function
-
Haskell, R.E., Carr, C.J., Pearce, D.A., Bennett, M.J. and Davidson, B.L. (2000) Batten disease: Evaluation of CLN3 mutations on protein localization and function. Hum. Mol. Genet., 9, 735-744.
-
(2000)
Hum. Mol. Genet.
, vol.9
, pp. 735-744
-
-
Haskell, R.E.1
Carr, C.J.2
Pearce, D.A.3
Bennett, M.J.4
Davidson, B.L.5
-
15
-
-
1542313968
-
Two motifs target Batten disease protein CLN3 to lysosomes in transfected non-neuronal and neuronal cells
-
Kyttälä, A., Ihrke, G., Vesa, J., Schell, M.J. and Luzio, J.P. (2003) Two motifs target Batten disease protein CLN3 to lysosomes in transfected non-neuronal and neuronal cells. Mol. Biol. Cell, 15, 1313-1323.
-
(2003)
Mol. Biol. Cell
, vol.15
, pp. 1313-1323
-
-
Kyttälä, A.1
Ihrke, G.2
Vesa, J.3
Schell, M.J.4
Luzio, J.P.5
-
16
-
-
0037226939
-
The neuronal ceroid-lipofucinoses
-
Haltia, M. (2003) The neuronal ceroid-lipofucinoses. J. Neuropathol. Exp. Neurol., 62, 1-13.
-
(2003)
J. Neuropathol. Exp. Neurol.
, vol.62
, pp. 1-13
-
-
Haltia, M.1
-
17
-
-
0026511672
-
Neurology of the neuronal ceroid-lipofuscinoses: Late infantile and Juvenile types
-
Boustany, M. (1992) Neurology of the neuronal ceroid-lipofuscinoses: late infantile and Juvenile types. Am. J. Med. Ge., 42, 533-535.
-
(1992)
Am. J. Med. Ge.
, vol.42
, pp. 533-535
-
-
Boustany, M.1
-
18
-
-
0000118993
-
Batten disease or neuronal ceroid lipofuscinosis
-
In Vinken, P.J., Bruyn, G.W. and Moser, H.W. (eds), Elsevier Sciences, New York
-
Boustany, M. (1996) Batten disease or neuronal ceroid lipofuscinosis. In Vinken, P.J., Bruyn, G.W. and Moser, H.W. (eds), Handbook of Clinical Neurology, Neurodystrophies and Neurolipidoses, Elsevier Sciences, New York, Vol. 66, pp. 671-900.
-
(1996)
Handbook of Clinical Neurology, Neurodystrophies and Neurolipidoses
, vol.66
, pp. 671-900
-
-
Boustany, M.1
-
19
-
-
0042863233
-
Optic nerve degeneration in a murine model of juvenile ceroid lipofuscinosis
-
Sappington, R.M., Pearce, D.A. and Calkins, D.J. (2003) Optic nerve degeneration in a murine model of juvenile ceroid lipofuscinosis. Invest. Ophthalmol. Vis. Sci., 44, 3725-3731.
-
(2003)
Invest. Ophthalmol. Vis. Sci.
, vol.44
, pp. 3725-3731
-
-
Sappington, R.M.1
Pearce, D.A.2
Calkins, D.J.3
-
20
-
-
0032744277
-
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium
-
[corrected]. [Erratum (2000) 7, 127.]
-
Mitchison, H.M., Bernard, D.J., Greene, N.D., Cooper, J.D., Junaid, M.A., Pullarkat, R.K., de Vos, N., Breuning, M.H., Owens, J.W., Mobley, W.C. et al. (1999) Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]. [Erratum (2000) Neurobiol. Dis., 7, 127.] Neurobiol. Dis., 6, 321-334.
-
(1999)
Neurobiol. Dis.
, vol.6
, pp. 321-334
-
-
Mitchison, H.M.1
Bernard, D.J.2
Greene, N.D.3
Cooper, J.D.4
Junaid, M.A.5
Pullarkat, R.K.6
de Vos, N.7
Breuning, M.H.8
Owens, J.W.9
Mobley, W.C.10
-
21
-
-
71749101489
-
An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease
-
Chattopadhyay, S., Ito, M., Cooper, J.D., Brooks, A.I., Curran, T.M., Powers, J.M. and Pearce, D.A. (2002) An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Hum. Mol. Genet., 11, 1421-1431.
-
(2002)
Hum. Mol. Genet.
, vol.11
, pp. 1421-1431
-
-
Chattopadhyay, S.1
Ito, M.2
Cooper, J.D.3
Brooks, A.I.4
Curran, T.M.5
Powers, J.M.6
Pearce, D.A.7
-
22
-
-
0037107348
-
Cln3 (Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth
-
Cotman, S.L., Vrbanac, V., Lebel, L.A., Lee, R.L., Johnson, K.A., Donahue, L.R., Teed, A.M., Antonellis, K., Bronson, R.T., Lerner, T.J. et al. (2002) Cln3 (Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth. Hum. Mol. Genet., 11, 2709-2721.
-
(2002)
Hum. Mol. Genet.
, vol.11
, pp. 2709-2721
-
-
Cotman, S.L.1
Vrbanac, V.2
Lebel, L.A.3
Lee, R.L.4
Johnson, K.A.5
Donahue, L.R.6
Teed, A.M.7
Antonellis, K.8
Bronson, R.T.9
Lerner, T.J.10
-
23
-
-
0030038060
-
Apoptosis as the mechanism of neurodegeneration in Batten's disease
-
Lane, S.C., Jolly, R.D., Schmechel, D.E., Alroy, J. and Boustany, M. (1996) Apoptosis as the mechanism of neurodegeneration in Batten's disease. J. Neurochem., 67, 677-683.
-
(1996)
J. Neurochem.
, vol.67
, pp. 677-683
-
-
Lane, S.C.1
Jolly, R.D.2
Schmechel, D.E.3
Alroy, J.4
Boustany, M.5
-
24
-
-
0030740542
-
Morphologic diagnosis in neuronal ceroid lipofiscinoses
-
Goebel, H.H. (1997) Morphologic diagnosis in neuronal ceroid lipofiscinoses. Neuropediatrics, 28, 67-69.
-
(1997)
Neuropediatrics
, vol.28
, pp. 67-69
-
-
Goebel, H.H.1
-
25
-
-
0036712747
-
Motifs within the CLN3 protein: Modulation of cell growth rates and apoptosis
-
Persaud-Sawin, D.A., VanDongen, A. and Boustany, M. (2002) Motifs within the CLN3 protein: Modulation of cell growth rates and apoptosis. Hum. Mol. Genet., 11, 2129-2142.
-
(2002)
Hum. Mol. Genet.
, vol.11
, pp. 2129-2142
-
-
Persaud-Sawin, D.A.1
VanDongen, A.2
Boustany, M.3
-
26
-
-
0032799217
-
CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide
-
Puranam, K.L., Guo, W.-X., Qian, W.-H., Nikbakht, K. and Boustany, M. (1999) CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide. Mol. Gen. Met., 66, 294-308.
-
(1999)
Mol. Gen. Met.
, vol.66
, pp. 294-308
-
-
Puranam, K.L.1
Guo, W.-X.2
Qian, W.-H.3
Nikbakht, K.4
Boustany, M.5
-
27
-
-
24644471460
-
Cell death pathways in juvenile Batten disease
-
Persaud-Sawin, D.-A. and Boustany, M. (2005) Cell death pathways in juvenile Batten disease. Apoptosis, 10, 973-985.
-
(2005)
Apoptosis
, vol.10
, pp. 973-985
-
-
Persaud-Sawin, D.-A.1
Boustany, M.2
-
28
-
-
0036468256
-
The CLN3 gene is a novel molecular target for cancer drug discovery
-
Rylova, S.N., Amalfitano, A., Persaud-Sawin, D.A., Guo, W.-X., Chang, J., Jansen, P.J., Proia, A.D. and Boustany, M. (2002) The CLN3 gene is a novel molecular target for cancer drug discovery. Cancer Res., 62, 801-808.
-
(2002)
Cancer Res.
, vol.62
, pp. 801-808
-
-
Rylova, S.N.1
Amalfitano, A.2
Persaud-Sawin, D.A.3
Guo, W.-X.4
Chang, J.5
Jansen, P.J.6
Proia, A.D.7
Boustany, M.8
-
29
-
-
33646269496
-
Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy
-
Buytaert, E., Callewaert, G., Hendrickx, N., Scorrano, L., Hartmann, D., Missiaen, L., Vandenheede, J.R., Heirman, I., Grooten, J. and Agostinis, P. (2006) Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. FASEB J., 20, 756-768.
-
(2006)
FASEB J.
, vol.20
, pp. 756-768
-
-
Buytaert, E.1
Callewaert, G.2
Hendrickx, N.3
Scorrano, L.4
Hartmann, D.5
Missiaen, L.6
Vandenheede, J.R.7
Heirman, I.8
Grooten, J.9
Agostinis, P.10
-
32
-
-
2042496266
-
Intracellular calcium modulates the nuclear translocation of calsenilin
-
Zaidi, N.F., Thomson, E.E., Choi, E.K., Buxbaum, J.D. and Wasco, W. (2004) Intracellular calcium modulates the nuclear translocation of calsenilin. J. Neurochem., 89, 593-601.
-
(2004)
J. Neurochem.
, vol.89
, pp. 593-601
-
-
Zaidi, N.F.1
Thomson, E.E.2
Choi, E.K.3
Buxbaum, J.D.4
Wasco, W.5
-
33
-
-
0141988727
-
Altered Aβ formation and long-term potentiation in a calsenilin knock-out
-
Lilliehook, C., Bozdagi, O., Yao, J., Gomez-Ramirez, M., Zaidi, N.F., Wasco, W., Gandy, S., Santucci, A.C., Haroutunian, V., Huntley, G.W. et al. (2003) Altered Aβ formation and long-term potentiation in a calsenilin knock-out. J. Neurosci., 23, 9097-9106.
-
(2003)
J. Neurosci.
, vol.23
, pp. 9097-9106
-
-
Lilliehook, C.1
Bozdagi, O.2
Yao, J.3
Gomez-Ramirez, M.4
Zaidi, N.F.5
Wasco, W.6
Gandy, S.7
Santucci, A.C.8
Haroutunian, V.9
Huntley, G.W.10
-
34
-
-
18244378838
-
DREAM is a critical transcriptional repressor for pain modulation
-
Cheng, H.Y., Pitcher, G.M., Laviolette, S.R., Whishaw, I.Q., Tong, K.I., Kockeritz, L.K., Wada, T., Joza, N.A., Crackower, M., Goncalves, J. et al. (2002) DREAM is a critical transcriptional repressor for pain modulation. Cell, 108, 31-43.
-
(2002)
Cell
, vol.108
, pp. 31-43
-
-
Cheng, H.Y.1
Pitcher, G.M.2
Laviolette, S.R.3
Whishaw, I.Q.4
Tong, K.I.5
Kockeritz, L.K.6
Wada, T.7
Joza, N.A.8
Crackower, M.9
Goncalves, J.10
-
35
-
-
0344867852
-
Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)
-
Järvelä, I., Lehtovirta, M., Tikknen, R., Kyttala, A. and Jalanko, A. (1999) Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL). Hum. Mol. Genet., 8, 1091-1098.
-
(1999)
Hum. Mol. Genet.
, vol.8
, pp. 1091-1098
-
-
Järvelä, I.1
Lehtovirta, M.2
Tikknen, R.3
Kyttala, A.4
Jalanko, A.5
-
36
-
-
0032905252
-
Action of BTN1, the yeast orthologue of the gene mutated in Batten disease
-
Pearce, D.A., Ferea, T., Nosel, S.A., Das, B. and Sherman, F. (1999) Action of BTN1, the yeast orthologue of the gene mutated in Batten disease. Nat. Genet., 22, 55-58.
-
(1999)
Nat. Genet.
, vol.22
, pp. 55-58
-
-
Pearce, D.A.1
Ferea, T.2
Nosel, S.A.3
Das, B.4
Sherman, F.5
-
37
-
-
0033764930
-
The yeast model for batten disease: Mutations in BTN1, BTN2 and HSP30 alter pH homeostasis
-
Chattopadhyay, S., Muzaffar, N.E., Sherman, F. and Pearce, D.A. (2000) The yeast model for batten disease: Mutations in BTN1, BTN2 and HSP30 alter pH homeostasis. J. Bacteriol., 22, 6418-6423.
-
(2000)
J. Bacteriol.
, vol.22
, pp. 6418-6423
-
-
Chattopadhyay, S.1
Muzaffar, N.E.2
Sherman, F.3
Pearce, D.A.4
-
38
-
-
28744438595
-
Defective lysosomal arginine transport in juvenile Batten disease
-
Ramirez-Montealegre, D. and Pearce, D.A. (2005) Defective lysosomal arginine transport in juvenile Batten disease. Hum. Mol. Genet., 14, 3759-3773.
-
(2005)
Hum. Mol. Genet.
, vol.14
, pp. 3759-3773
-
-
Ramirez-Montealegre, D.1
Pearce, D.A.2
-
39
-
-
0347364649
-
A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease
-
Kim, Y., Ramirez-Montealegre, D. and Pearce, D.A. (2003) A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease. Proc. Natl Acad. Sci. USA., 23, 15458-15462.
-
(2003)
Proc. Natl Acad. Sci. USA
, vol.23
, pp. 15458-15462
-
-
Kim, Y.1
Ramirez-Montealegre, D.2
Pearce, D.A.3
-
40
-
-
0035170833
-
Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs)
-
Holopainen, J.M., Saarikoski, J., Kinnunen, P.K. and Jarvela, I. (2001) Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs). Eur. J. Biochem., 268, 5851-5856.
-
(2001)
Eur. J. Biochem.
, vol.268
, pp. 5851-5856
-
-
Holopainen, J.M.1
Saarikoski, J.2
Kinnunen, P.K.3
Jarvela, I.4
-
41
-
-
33745976466
-
Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis
-
Cao, Y., Espinola, J.A., Fossale, E., Massey, A.C., Cuervo, A.M., MacDonald, M.E. and Cotman, S.L. (2006) Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. J. Biol. Chem., 281, 20483-20493.
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 20483-20493
-
-
Cao, Y.1
Espinola, J.A.2
Fossale, E.3
Massey, A.C.4
Cuervo, A.M.5
MacDonald, M.E.6
Cotman, S.L.7
-
42
-
-
0026539541
-
Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease)
-
Palmer, D.N., Fearnley, I.M., Walker, J.E., Hall, N.A., Lake, B.D., Wolfe, L.S., Haltia, M., Martinus, R.D. and Jolly, R.D. (1992) Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am. J. Med. Genet., 42, 561-567.
-
(1992)
Am. J. Med. Genet.
, vol.42
, pp. 561-567
-
-
Palmer, D.N.1
Fearnley, I.M.2
Walker, J.E.3
Hall, N.A.4
Lake, B.D.5
Wolfe, L.S.6
Haltia, M.7
Martinus, R.D.8
Jolly, R.D.9
-
43
-
-
9744254471
-
Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway
-
Luiro, K., Yliannala, K., Ahtiainen, L., Maunu, H., Jarvela, I., Kyttala, A. and Jalanko, A. (2004) Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway. Hum. Mol. Genet., 13, 3017-3027.
-
(2004)
Hum. Mol. Genet.
, vol.13
, pp. 3017-3027
-
-
Luiro, K.1
Yliannala, K.2
Ahtiainen, L.3
Maunu, H.4
Jarvela, I.5
Kyttala, A.6
Jalanko, A.7
-
44
-
-
0036326358
-
Neuronal ceroid lipofuscinoses are connected at molecular level interaction of CLN5 protein with CLN2 and CLN3
-
Vesa, J., Chin, M.H., Oelgeschlager, K., Isosomppi, J., DellAngelica, E.C., Jalanko, A. and Peltonen, L. (2002) Neuronal ceroid lipofuscinoses are connected at molecular level interaction of CLN5 protein with CLN2 and CLN3. Mol. Biol. Cell, 13, 2410-2420.
-
(2002)
Mol. Biol. Cell
, vol.13
, pp. 2410-2420
-
-
Vesa, J.1
Chin, M.H.2
Oelgeschlager, K.3
Isosomppi, J.4
DellAngelica, E.C.5
Jalanko, A.6
Peltonen, L.7
-
45
-
-
0029977497
-
Mutations in the Drosophila hook gene inhibit endocytosis of the boss transmembrane ligand into multivesicular bodies
-
Kramer, H. and Phistry, M. (1996) Mutations in the Drosophila hook gene inhibit endocytosis of the boss transmembrane ligand into multivesicular bodies. J. Cell Biol., 133, 1205-1215.
-
(1996)
J. Cell Biol.
, vol.133
, pp. 1205-1215
-
-
Kramer, H.1
Phistry, M.2
-
46
-
-
9744278990
-
A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging
-
Kopra, O., Vesa, J., von Schantz, C., Manninen, T., Minye, H., Fabritius, A.L., Rapola, J., van Diggelen, O.P., Saarela, J., Jalanko, A. et al. (2004) A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging. Hum. Mol. Genet., 13, 2893-2906.
-
(2004)
Hum. Mol. Genet.
, vol.13
, pp. 2893-2906
-
-
Kopra, O.1
Vesa, J.2
von Schantz, C.3
Manninen, T.4
Minye, H.5
Fabritius, A.L.6
Rapola, J.7
van Diggelen, O.P.8
Saarela, J.9
Jalanko, A.10
|